Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Internal and Emergency Medicine
Published in: Internal and Emergency Medicine 2/2009

01-04-2009 | CE - Letter to the Editor

Contrast-enhanced MRI to recognize myocarditis with STEMI presentation

Authors: Giovanni Salvatore Camastra, Luca Cacciotti, Raffaella Semeraro, Fabio Marconi, Stefano Sbarbati, Massimiliano Danti, Sabino Della Sala, Gerardo Ansalone

Published in: Internal and Emergency Medicine | Issue 2/2009

Login to get access

Excerpt

Myocarditis is difficult to recognize in the early phase particularly when it mimics acute myocardial infarction (STEMI). New strategies to diagnose active myocarditis are needed to avoid unnecessary coronary angiography in such an acute setting. Contrast-enhanced magnetic resonance imaging (MRI) is able to discriminate the small myocardial injuries due to myocarditis from the segmental lesions of ischemic origin. …
Literature
1.
Mahrholdt H, Goedecke C, Wagner A et al (2004) Cardiovascular magnetic resonance assessment of human myocarditis a comparison to histology and molecular pathology. Circulation 109:1250–1258PubMedCrossRef
2.
Brady RR, Perron AD, Martin ML et al (2001) Cause of ST-segment abnormality in ED chest pain patients. Am J Emerg Med 19:25PubMedCrossRef
3.
Wang K, Asinger RW, Marriott HJL (2003) ST-segment elevation in conditions other than acute myocardial infarction. N Engl J Med 349:2128–2135PubMedCrossRef
4.
Sharkey SW, Berger CR, Brunette DD, Henry TD (1994) Impact of the electrocardiogram on the delivery of thrombolytic therapy for acute myocardial infarction. Am J Cardiol 73:550–553PubMedCrossRef
5.
Khoury NE, Borzak S, Gokli A, Havstad SL, Smith ST, Jones M (1996) “Inadvertent” thrombolytic administration in patients without myocardial infarction: clinical features and outcome. Ann Emerg Med 28:289–293PubMedCrossRef
Metadata
Title
Contrast-enhanced MRI to recognize myocarditis with STEMI presentation
Authors
Giovanni Salvatore Camastra
Luca Cacciotti
Raffaella Semeraro
Fabio Marconi
Stefano Sbarbati
Massimiliano Danti
Sabino Della Sala
Gerardo Ansalone
Publication date
01-04-2009
Publisher
Springer Milan
Published in
Internal and Emergency Medicine / Issue 2/2009
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-008-0223-2

Other articles of this Issue 2/2009

Internal and Emergency Medicine 2/2009 Go to the issue

CE - Letter to the Editor

Anticoagulation for portal vein thrombosis in cirrhotic patients should be always considered

CE - Letter to the Editor

An atypical vascular case of Behçet’s disease and consequent treatment

IM- Review

Molecular and clinical aspects of endothelial dysfunction in diabetes

CE - Letter to the Editor

Are we aware of ecstasy effects?

CE - Letter to the Editor

Thyroid storm with atypical neurological signs: an unusual clinical emergence of a life-threatening event

IM - Case Record

A sudden neurological deficit in a patient with endocarditis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits